USP Opens New Brazilian Facility

September 29, 2008

The U.S. Pharmacopeia (Rockville, MD) opened a new, 1800-sq-meter facility in the Wtorre Technology Park in Sao Paulo, Brazil, on August 18. The facility, situated close to several of USP’s pharmaceutical clients, contains state-of-the-art office and laboratory space that the organization will use to dispense its publications and reference standards to local manufacturers.

The U.S. Pharmacopeia (Rockville, MD) opened a new, 1800-sq-meter facility in the Wtorre Technology Park in Sao Paulo, Brazil, on August 18.

The facility, situated close to several of USP’s pharmaceutical clients, contains state-of-the-art office and laboratory space that the organization will use to dispense its publications and reference standards to local manufacturers.

“This new site demonstrates USP’s commitment to ensuring the quality and safety of pharmaceuticals, dietary supplements, and food ingredients for everyone, regardless of geographic, economic, or political borders,” said USP executive vice president and CEO Roger Williams, MD. “As the world continues to focus on these issues, it is even more important for standard-setting bodies and governments to collaborate. This office and laboratory facility will help USP work with Brazilian regulators and manufacturers to move toward that goal.”

Flavio Vormittag, MD, vice president of USP Brazil, added that the company will work closely with the National Health Surveillance Agency (Brasilia, Brazil), the Brazilian Federation of the Pharmaceutical Industry (Brasilia, Brazil), and other organizations to ensure the quality of medicines and food ingredients.

“Our presence will benefit Brazilian manufacturers, government agencies, and ultimately patients in Brazil, the United States, and the many countries to which Brazil exports,” Vormittag said.